日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/04/04 | 1,458 | 1,467 | 1,451 | 1,467 | -3 | -0.2% | 1,500 |
| 2025/04/03 | 1,474 | 1,474 | 1,451 | 1,470 | -9 | -0.6% | 6,500 |
| 2025/04/02 | 1,485 | 1,485 | 1,479 | 1,479 | -1 | -0.1% | 700 |
| 2025/04/01 | 1,494 | 1,494 | 1,480 | 1,480 | +1 | +0.1% | 700 |
| 2025/03/31 | 1,483 | 1,500 | 1,474 | 1,479 | -5 | -0.3% | 1,300 |
| 2025/03/28 | 1,482 | 1,490 | 1,471 | 1,484 | -35 | -2.3% | 17,300 |
| 2025/03/27 | 1,525 | 1,525 | 1,513 | 1,519 | -6 | -0.4% | 3,500 |
| 2025/03/26 | 1,519 | 1,525 | 1,519 | 1,525 | +5 | +0.3% | 2,700 |
| 2025/03/25 | 1,517 | 1,520 | 1,516 | 1,520 | +9 | +0.6% | 2,300 |
| 2025/03/24 | 1,519 | 1,520 | 1,481 | 1,511 | +4 | +0.3% | 2,600 |
| 2025/03/21 | 1,505 | 1,507 | 1,501 | 1,507 | +2 | +0.1% | 700 |
| 2025/03/19 | 1,505 | 1,505 | 1,501 | 1,505 | +3 | +0.2% | 700 |
| 2025/03/18 | 1,497 | 1,509 | 1,495 | 1,502 | +5 | +0.3% | 900 |
| 2025/03/17 | 1,498 | 1,510 | 1,497 | 1,497 | +2 | +0.1% | 4,900 |
| 2025/03/14 | 1,498 | 1,499 | 1,484 | 1,495 | -3 | -0.2% | 1,100 |
| 2025/03/13 | 1,485 | 1,498 | 1,485 | 1,498 | +13 | +0.9% | 1,300 |
| 2025/03/12 | 1,488 | 1,488 | 1,485 | 1,485 | -4 | -0.3% | 300 |
| 2025/03/11 | 1,495 | 1,495 | 1,489 | 1,489 | -6 | -0.4% | 1,100 |
| 2025/03/10 | 1,490 | 1,495 | 1,490 | 1,495 | ±0 | ±0% | 1,200 |
| 2025/03/07 | 1,481 | 1,495 | 1,481 | 1,495 | +13 | +0.9% | 1,400 |
| 2025/03/06 | 1,492 | 1,495 | 1,480 | 1,482 | -18 | -1.2% | 2,800 |
| 2025/03/05 | 1,487 | 1,500 | 1,487 | 1,500 | ±0 | ±0% | 1,100 |
| 2025/03/04 | 1,488 | 1,508 | 1,488 | 1,500 | +13 | +0.9% | 2,500 |
| 2025/03/03 | 1,478 | 1,490 | 1,475 | 1,487 | +19 | +1.3% | 1,600 |
| 2025/02/28 | 1,464 | 1,490 | 1,464 | 1,468 | -8 | -0.5% | 4,400 |
| 2025/02/27 | 1,470 | 1,485 | 1,470 | 1,476 | +6 | +0.4% | 3,700 |
| 2025/02/26 | 1,469 | 1,480 | 1,465 | 1,470 | -7 | -0.5% | 2,300 |
| 2025/02/25 | 1,467 | 1,478 | 1,467 | 1,477 | +13 | +0.9% | 1,700 |
| 2025/02/21 | 1,465 | 1,470 | 1,464 | 1,464 | ±0 | ±0% | 1,600 |
| 2025/02/20 | 1,467 | 1,475 | 1,462 | 1,464 | +2 | +0.1% | 2,700 |
| 2025/02/19 | 1,479 | 1,479 | 1,462 | 1,462 | -5 | -0.3% | 1,300 |
| 2025/02/18 | 1,466 | 1,467 | 1,463 | 1,467 | +2 | +0.1% | 2,800 |
| 2025/02/17 | 1,469 | 1,473 | 1,464 | 1,465 | -13 | -0.9% | 4,100 |
| 2025/02/14 | 1,478 | 1,478 | 1,478 | 1,478 | ±0 | ±0% | 100 |
| 2025/02/13 | 1,470 | 1,478 | 1,470 | 1,478 | +8 | +0.5% | 1,400 |
| 2025/02/12 | 1,467 | 1,470 | 1,465 | 1,470 | ±0 | ±0% | 600 |
| 2025/02/10 | 1,468 | 1,470 | 1,467 | 1,470 | +3 | +0.2% | 1,500 |
| 2025/02/07 | 1,466 | 1,470 | 1,464 | 1,467 | -3 | -0.2% | 2,100 |
| 2025/02/06 | 1,470 | 1,475 | 1,465 | 1,470 | -1 | -0.1% | 3,100 |
| 2025/02/05 | 1,470 | 1,478 | 1,469 | 1,471 | +1 | +0.1% | 2,700 |
| 2025/02/04 | 1,477 | 1,477 | 1,470 | 1,470 | -8 | -0.5% | 800 |
| 2025/02/03 | 1,465 | 1,478 | 1,452 | 1,478 | +26 | +1.8% | 8,800 |
| 2025/01/31 | 1,466 | 1,467 | 1,450 | 1,452 | +30 | +2.1% | 11,900 |
| 2025/01/30 | 1,482 | 1,490 | 1,422 | 1,422 | -64 | -4.3% | 34,700 |
| 2025/01/29 | 1,491 | 1,497 | 1,486 | 1,486 | -5 | -0.3% | 1,400 |
| 2025/01/28 | 1,486 | 1,502 | 1,486 | 1,491 | +1 | +0.1% | 1,500 |
| 2025/01/27 | 1,483 | 1,499 | 1,483 | 1,490 | +6 | +0.4% | 4,300 |
| 2025/01/24 | 1,483 | 1,497 | 1,483 | 1,484 | ±0 | ±0% | 3,200 |
| 2025/01/23 | 1,482 | 1,494 | 1,482 | 1,484 | -10 | -0.7% | 2,600 |
| 2025/01/22 | 1,478 | 1,496 | 1,478 | 1,494 | +11 | +0.7% | 2,100 |
1～
50
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 146,700円 | +2.5% | - | 3.41% | 88.21倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| ペルセウス | 43,300円 | +20.0% | - | 0.00% | - | 3.63倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体（ＡＤＣ）開発 |
| ノイルイミューン | 14,700円 | -28.6% | - | 0.00% | - | 1.35倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
| ＮＰＴ | - | - | - | - | - | - |
|
- |
| モダリス | 7,800円 | - | - | 0.00% | - | 1.63倍 |
|
遺伝子治療薬の創薬ベンチャー、ＤＮＡ切断しないエピゲノム編集に強み。研究開発中心は米国 |
市場注目の銘柄
チャート関連のコラム
